⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOBT News
IO Biotech, Inc. Common Stock
Recurrent Head And Neck Squamous Cell Carcinoma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 65+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
GSK
JNJ
MRK
REGN
BIIB
EXEL
IOBT
INO
GMAB
IMUX
NVCR
PDSB
BNTX
CRSP
MRNA
RPTX
PRE
TRNS
INVZ
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight
globenewswire.com
MRK
AZN
IOBT
ABBV
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Elevara Medicines Appoints Biotech Veteran as CEO
globenewswire.com
IOBT
Delisting of Securities from The Nasdaq Stock Market
globenewswire.com
MLGO
EPWK
IVP
SYNX
TWIN
FAT
CASI
TRX
ITRM
IOBT
Form 8-K
sec.gov
IOBT
Bavarian Nordic A/S – Notice Convening Annual General Meeting
globenewswire.com
JNJ
UCB
GSK
SNY
VICR
IOBT
FLS
IQV
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
IO Biotech Provides Corporate Update
globenewswire.com
IOBT
IO Biotech Announces Exploration of Strategic Alternatives
globenewswire.com
IOBT